139 related articles for article (PubMed ID: 37926541)
21. Treatment of acute kidney injury with cast nephropathy.
Walther C; Podoll AS; Finkel KW
Clin Nephrol; 2014 Jul; 82(1):1-6. PubMed ID: 24725380
[TBL] [Abstract][Full Text] [Related]
22. Lambda Light Chain Non-crystalline Proximal Tubulopathy with IgD Lambda Myeloma.
Kishi S; Obata F; Miki H; Matsuura M; Nishimura K; Tamaki M; Kishi F; Murakami T; Abe H; Nagai K; Abe M; Doi T
Intern Med; 2018 Dec; 57(24):3597-3602. PubMed ID: 30101939
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of blood purification and bortezomib plus dexamethasone therapy for the treatment of acute renal failure due to myeloma cast nephropathy.
Hasegawa M; Kondo F; Yamamoto K; Murakami K; Tomita M; Nabeshima K; Nakai S; Kato M; Ohashi A; Arai J; Hiki Y; Ishii J; Emi N; Sugiyama S; Yuzawa Y
Ther Apher Dial; 2010 Oct; 14(5):451-6. PubMed ID: 21175542
[TBL] [Abstract][Full Text] [Related]
24. Mechanism and prevention of acute kidney injury from cast nephropathy in a rodent model.
Ying WZ; Allen CE; Curtis LM; Aaron KJ; Sanders PW
J Clin Invest; 2012 May; 122(5):1777-85. PubMed ID: 22484815
[TBL] [Abstract][Full Text] [Related]
25. Effectiveness of Haemodiafiltration with Heat Sterilized High-Flux Polyphenylene HF Dialyzer in Reducing Free Light Chains in Patients with Myeloma Cast Nephropathy.
Rousseau-Gagnon M; Agharazii M; De Serres SA; Desmeules S
PLoS One; 2015; 10(10):e0140463. PubMed ID: 26466100
[TBL] [Abstract][Full Text] [Related]
26. Bortezomib-based chemotherapy for light chain deposition disease presenting as acute renal failure.
Gharwan H; Truica CI
Med Oncol; 2012 Jun; 29(2):1197-201. PubMed ID: 21479696
[TBL] [Abstract][Full Text] [Related]
27. [Withdrawal of maintenance dialysis in a patient with diagnosed multiple myeloma and renal failure as a consequence of effective anti-tumor treatment].
Rosa J; Sydor A; Jurczyszyn A; Zabawa-Hołyś S; Nowak J; Czapkowicz-Gryszkiewicz L; Sułowicz W
Przegl Lek; 2010; 67(7):547-50. PubMed ID: 21387773
[TBL] [Abstract][Full Text] [Related]
28. Renal biopsy diagnosis of clinically silent multiple myeloma.
Border WA; Cohen AH
Ann Intern Med; 1980 Jul; 93(1):43-6. PubMed ID: 7396312
[TBL] [Abstract][Full Text] [Related]
29. Light chains removal by extracorporeal techniques in acute kidney injury due to multiple myeloma: a position statement of the Onconephrology Work Group of the Italian Society of Nephrology.
Fabbrini P; Finkel K; Gallieni M; Capasso G; Cavo M; Santoro A; Pasquali S
J Nephrol; 2016 Dec; 29(6):735-746. PubMed ID: 27757797
[TBL] [Abstract][Full Text] [Related]
30. Treatment by long haemodialysis sessions with high cut-off filters in myeloma cast nephropathy: our experience.
Borrego-Hinojosa J; Pérez-del Barrio MP; Biechy-Baldan Mdel M; Merino-García E; Sánchez-Perales MC; García-Cortés MJ; Ocaña-Pérez E; Gutiérrez-Rivas P; Liébana-Cañada A
Nefrologia; 2013; 33(4):515-23. PubMed ID: 23897183
[TBL] [Abstract][Full Text] [Related]
31. Reversible acute kidney injury (AKI) by active removal of serum light chains in an HIV positive patient with myeloma kidney.
Sowole L; Burns A; Kaur B; Davenport A
Clin Nephrol; 2011 Nov; 76(5):417-20. PubMed ID: 22000564
[TBL] [Abstract][Full Text] [Related]
32. Multiple myeloma can be accurately diagnosed in acute kidney injury patients using a rapid serum free light chain test.
Heaney JLJ; Campbell JP; Yadav P; Griffin AE; Shemar M; Pinney JH; Drayson MT
BMC Nephrol; 2017 Jul; 18(1):247. PubMed ID: 28728609
[TBL] [Abstract][Full Text] [Related]
33. Treating myeloma cast nephropathy without treating myeloma.
Leung N
J Clin Invest; 2012 May; 122(5):1605-8. PubMed ID: 22484811
[TBL] [Abstract][Full Text] [Related]
34. Management of acute kidney injury in frail patients with biopsy-proven cast nephropathy: a combined approach with chemotherapy plus Supra-hemodiafiltration with post-adsorption endogenous reinfusion.
Murgia S; Quattrocchio G; Forneris G; Pozzato M; Fenoglio R; Ferro M; De Simone E; Del Vecchio G; Di Benedetto C; Roccatello D
J Nephrol; 2022 May; 35(4):1243-1249. PubMed ID: 34982413
[TBL] [Abstract][Full Text] [Related]
35. A non-invasive differential diagnostic model for light chain cast nephropathy in newly diagnosed multiple myeloma patients with renal involvement: a multicenter study.
Lin ZS; Qin AB; Wang SX; Yu XJ; Dong B; Xiong ZY; Chen MH; Zhou FD; Zhao MH
J Nephrol; 2021 Aug; 34(4):1169-1177. PubMed ID: 33394345
[TBL] [Abstract][Full Text] [Related]
36. Cast nephropathy with acute renal failure treated with high cut-off haemodialysis in a patient with multiple myeloma.
Shum HP; Chan KC; Chow CC; Kho BC; Yan WW
Hong Kong Med J; 2010 Dec; 16(6):489-92. PubMed ID: 21135429
[TBL] [Abstract][Full Text] [Related]
37. Light chain crystalline kidney disease: diagnostic urine microscopy as the "liquid kidney biopsy".
Luciano RL; Castano E; Fogazzi GB; Perazella MA
Clin Nephrol; 2014 Dec; 82(6):387-91. PubMed ID: 25295579
[TBL] [Abstract][Full Text] [Related]
38. [Improved prognosis in light chain nephropathy due to multiple myeloma].
Juul JS; Larsen T; Marcussen N; Pedersen EB
Ugeskr Laeger; 2012 Apr; 174(17):1159-60. PubMed ID: 22533933
[TBL] [Abstract][Full Text] [Related]
39. Myeloma cast nephropathy with diffuse amyloid casts without systemic amyloidosis: two cases report.
Yong ZH; Yu XJ; Lin ZS; Zhou FD; Cen XN; Wang SX; Zhao MH
BMC Nephrol; 2021 Jan; 22(1):6. PubMed ID: 33407225
[TBL] [Abstract][Full Text] [Related]
40. Prognostic value of kidney biopsy in myeloma cast nephropathy: a retrospective study of 70 patients.
Ecotière L; Thierry A; Debiais-Delpech C; Chevret S; Javaugue V; Desport E; Belmouaz S; Quellard N; Kaaki S; Goujon JM; Fermand JP; Touchard G; Bridoux F
Nephrol Dial Transplant; 2016 Jan; 31(1):64-72. PubMed ID: 26289418
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
